Ketamine-Augmented Psychotherapy – General Information

 

Treatment Framework

Ketamine therapy is used as an adjunctive treatment within a structured, comprehensive psychiatric and psychotherapeutic treatment plan. It is provided exclusively following a careful assessment and determination of indication by a medical specialist and under continuous medical supervision.

The aim is not the isolated administration of a substance, but its therapeutic integration into a clearly defined psychotherapeutic process.

Indications

Ketamine-augmented treatment may be considered in selected cases, particularly for:

• depressive disorders

• treatment-resistant conditions

• anxiety disorders

• post-traumatic stress disorder (PTSD)

• complex mood disorders

The decision is made on an individual basis following a comprehensive psychiatric and physical assessment.

Scientific Context

Ketamine has been used in medicine for many years. In recent years, its potential role as an adjunctive approach within psychotherapeutic treatment has been the subject of extensive scientific research.

Among the mechanisms being investigated is the temporary modulation of neurobiological processes that may be associated with increased neuronal adaptability and plasticity. This period is utilized exclusively within the context of structured psychotherapeutic support.

Legal Framework

Ketamine is used in what is known as off-label use, meaning that it is administered for an indication outside the scope of its original regulatory approval.

Treatment is provided under medical responsibility, following comprehensive informed consent, and in accordance with the applicable legal and regulatory requirements.

Coverage by statutory health insurance is generally not available.